Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

Wells Fargo analyst Derek Archila maintained a Buy rating on aTyr Pharma (ATYR – Research Report) yesterday and set a price target of $17.00. The company’s shares closed yesterday at $3.99.

The Canadian manufacturer D-Wave Quantum Inc. announced on Wednesday that it had solved a useful problem for the first time with a quantum computer that surpasses the capabilities of conventional ...

“There are signs these will come with an M4 Max but that its new Ultra chip will actually be an M3 Ultra,” Gurman says. With an M3 Ultra going into the Mac Studio, Apple could differentiate ...

Amanda Litman, co-founder and president of Run For Something, talks with Rachel Maddow about the record levels of interest in running for office since the start of the new Trump term, and the ...

The occasion was the 2025 PRWeek Healthcare Awards, a celebration of the sector that crafts the public’s perception of pharmaceutical ... banner emblazoned with logos of corporate sponsors.

One such supplement, Glyco Max Fix Gold, has emerged as a noteworthy option for those seeking to maintain healthy glycogen levels and enhance overall wellness. This product is designed to provide ...

The Porto project, Eco Wave Power's first MW-scale wave energy venture in the country, is expected to be finalized during 2026. Central to this initiative is the transformation of an existing ...

TEL AVIV, Israel, Feb. 27, 2025 /PRNewswire/ -- Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based ...

“2024 was another transformational year for Verona Pharma with the US approval and launch of Ohtuvayre (ensifentrine), the first novel inhaled therapy available for the maintenance treatment of ...